131 related articles for article (PubMed ID: 8643395)
1. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
Puttaraju M; Been MD
Nucleic Acids Symp Ser; 1995; (33):49-51. PubMed ID: 8643395
[TBL] [Abstract][Full Text] [Related]
2. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
Puttaraju M; Been MD
Nucleic Acids Symp Ser; 1995; (33):152-5. PubMed ID: 8643355
[TBL] [Abstract][Full Text] [Related]
3. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
[TBL] [Abstract][Full Text] [Related]
4. HIV gene regulatory proteins tat and rev and their interactions with synthetic RNA.
Asseline U; Grasby J; Hamy F; Iwai S; Mann DA; Pritchard C; Karn J; Gait MJ
Nucleic Acids Symp Ser; 1993; (29):113-4. PubMed ID: 7504239
[TBL] [Abstract][Full Text] [Related]
5. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
6. Circularizing ribozymes and decoy-competitors by autocatalytic splicing in vitro and in vivo.
Puttaraju M; Been MD
SAAS Bull Biochem Biotechnol; 1996; 9():77-82. PubMed ID: 8652136
[TBL] [Abstract][Full Text] [Related]
7. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
Peterson RD; Feigon J
J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
[TBL] [Abstract][Full Text] [Related]
8. RNA binding by the tat and rev proteins of HIV-1.
Karn J; Dingwall C; Finch JT; Heaphy S; Gait MJ
Biochimie; 1991 Jan; 73(1):9-16. PubMed ID: 1903308
[TBL] [Abstract][Full Text] [Related]
9. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
10. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of a non-nucleotide bridge into hairpin oligonucleotides capable of high-affinity binding to the Rev protein of HIV-1.
Nelson JS; Giver L; Ellington AD; Letsinger RL
Biochemistry; 1996 Apr; 35(16):5339-44. PubMed ID: 8611522
[TBL] [Abstract][Full Text] [Related]
12. [RNA ligands for HIV proteins].
Iwai S
Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944
[No Abstract] [Full Text] [Related]
13. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
Charpentier B; Stutz F; Rosbash M
J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
[TBL] [Abstract][Full Text] [Related]
14. Interaction of HIV Tat model peptides with tRNA and 5S rRNA.
Giel-Pietraszuk M; Barciszewska MZ; Mucha P; Rekowski P; Kupryszewski G; Barciszewski J
Acta Biochim Pol; 1997; 44(3):591-600. PubMed ID: 9511968
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of circular Bacillus subtilis RNase P RNA; activation by RNase P protein.
Puttaraju M; Beebe JA; Niranjanakumari S; Been MD; Fierke CA
Nucleic Acids Symp Ser; 1995; (33):92-4. PubMed ID: 8643411
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
17. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
[TBL] [Abstract][Full Text] [Related]
18. Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
Lisziewicz J; Zeng G; Gratas C; Weinstein JN; Lori F
Hum Gene Ther; 2000 Apr; 11(6):807-15. PubMed ID: 10779158
[TBL] [Abstract][Full Text] [Related]
19. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
20. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
